Actively Recruiting

Age: 18Years +
All Genders
ID07614386

Radial Access Data in Vascular Interventions: A Prospective Observational Registry Study

Led by Mersin Medicalpark Hastanesi · Updated on 2026-06-01

20000

Participants Needed

1

Research Sites

20 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The RADIUS study is a prospective observational registry focused on collecting real-world data about radial and ulnar artery access during percutaneous vascular interventions. It aims to evaluate procedural details, access-site complications, procedural success, and short-term clinical outcomes associated with these access methods. The study highlights the growing use of radial and ulnar access techniques as alternatives to traditional femoral access, given their potential benefits in patient safety and comfort. Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled from May 2026 through May 2031. The registry collects demographic, clinical, angiographic, procedural, and post-procedural data as part of standard clinical care. Expansion to multiple centers is planned following regulatory approvals, but no experimental treatments or devices are involved. Participants will have data collected from procedural reports, hospital records, and clinical evaluations covering variables such as cardiovascular risks, comorbidities, procedural duration, fluoroscopy time, contrast volume, and complications. Researchers will monitor outcomes including radial artery occlusion, spasm, vascular complications, procedural success, crossover rates, bleeding, length of hospital stay, and more for up to one year after the procedure. The study is purely observational and integrates with routine care without altering treatment plans.

CONDITIONS

Brief Title

Radial Access Data in Vascular Interventions Registry

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Undergoing routine percutaneous vascular interventions via radial or ulnar artery access
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Procedures performed without radial or ulnar artery access
  • Incomplete procedural or clinical data
  • Refusal to participate in the registry

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 1 year after the procedure

Participants who undergo routine percutaneous vascular interventions via radial or ulnar artery access are observed. Data on procedural characteristics, vascular complications, and clinical outcomes are collected from procedural reports, hospital records, and routine clinical evaluations.

Assessments during hospital stay and follow-up visits up to 1 year

Trial Site Locations

Total: 1 location

1

Mersin Medicalpark hospital

Mersin, Mezitli, Turkey (Türkiye), 33010

Actively Recruiting

Loading map...

Research Team

S

Sefa SURAL, MD

G

Gökhan AVCI, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Elut...

Elevated Lipoprotein(a) Level

Actively Recruiting

1 location

A 10-Minute Cardiovascular Magnetic Resonance Protocol for C...

Coronary Artery Disease

Actively Recruiting

1 location

A Danish Study to Assess the Efficacy of Implantable Cardiov...

Coronary Artery Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here